Molecular Targets 2021: The Latest Efforts to Overcome Resistance to KRAS Inhibitors
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
Tag: KRAS inhibitors
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...